JPS5951795A - Novel antibiotic sf-2198 substance and its preparation - Google Patents

Novel antibiotic sf-2198 substance and its preparation

Info

Publication number
JPS5951795A
JPS5951795A JP57162291A JP16229182A JPS5951795A JP S5951795 A JPS5951795 A JP S5951795A JP 57162291 A JP57162291 A JP 57162291A JP 16229182 A JP16229182 A JP 16229182A JP S5951795 A JPS5951795 A JP S5951795A
Authority
JP
Japan
Prior art keywords
substance
water
antibiotic
salt
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP57162291A
Other languages
Japanese (ja)
Inventor
Tatsuo Ito
辰男 伊藤
Norio Ezaki
江崎 紀夫
Takashi Shomura
庄村 喬
Kazuo Okano
岡野 一男
Masaji Sezaki
瀬崎 正次
Tomizo Niwa
丹羽 富造
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Priority to JP57162291A priority Critical patent/JPS5951795A/en
Publication of JPS5951795A publication Critical patent/JPS5951795A/en
Pending legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

PURPOSE:To prepare a novel antibiotic SF-2198 substance or its salt showing extremely high antibacterial activity against Gram-positive and Gram-negative bacteria, by cultivating a bacterium belonging to the genus Actinomadura. CONSTITUTION:A bacterium such as Actinomadura sp. SF-2198 strain (FREM-P 6650) belonging to the genus Actinomadura, capable of producing antibiotic SF- 2198 substance is cultivated at 26-36 deg.C for 5-15 days preferably in agar, antibiotic SF-2198 substance is collected mainly from a culture filtrate, and it is preferably converted into hydrochloride.

Description

【発明の詳細な説明】 本発明は新規抗生物質およびその製造法に関するもので
あり、さらに詳しくは抗生物質8F−2198物質およ
びその塩、およびアクチノマデユラ(Act inom
adura )属に属する抗生物質8F−2198物質
生産菌を培地に培養し、得られた培養物から抗生物質8
F−2198物質又はその塩を採取することを特徴とす
る新規抗生物質5F−2198物質又はその垣の製造法
に関するものである。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel antibiotic and a method for producing the same, and more specifically, the antibiotic 8F-2198 substance and its salts, and
Antibiotic 8F-2198 substance-producing bacteria belonging to the genus P. adura were cultured in a medium, and from the obtained culture
The present invention relates to a method for producing a novel antibiotic 5F-2198 substance or a substance thereof, which is characterized by collecting the F-2198 substance or a salt thereof.

本発明者らは、ある種の菌株の培養物中にグラム陽性菌
および陰性菌に対して抗菌作用を示す物質が生産されて
いることを見出し、その有効物質を培養物から純粋に単
離し、その性状を調べた結果、既知の物質とは異なる新
規物質であることを確かめ、この有効物質を8P−21
98物質と命名した。
The present inventors have discovered that a substance exhibiting antibacterial activity against Gram-positive and Gram-negative bacteria is produced in the culture of certain bacterial strains, and the active substance has been isolated purely from the culture. As a result of investigating its properties, it was confirmed that it was a new substance different from known substances, and this active substance was identified as 8P-21.
It was named 98 substances.

したがって第一の本発明は、白色ないし淡黄色の塩基性
物質であり、その塩酸塩は白色ないし淡黄色粉末であり
、水、メタノールに易溶、酢酸エチル、クロロホルム、
アルカリ性水に難溶であり、その分子量についてセカン
ダリイ・イオン質量スペクトル法で測定すると、M/Z
 、95.2.854゜822.511にイオン・ピー
クを示し、その分解点は150℃付近であシ、比旋光度
は〔α几5−232゜(c O15、水)であり、第1
図に示す通りの紫外線吸収スペクトルと第2図に示す通
りの赤外線吸収スはクトルを示し、呈色反応はレミュー
、ヨード試薬に対し陽性でニンヒドリン、板目試薬に対
し陰性であり、シリカゲル薄層クロマトグラフィーでの
nf値は、 Rf=0,76Cクロロホルム−メタノール;5:1)
T’Cf=0.67(ブタノール−酢酸−水;2:1:
1)   ′Rf=0.71(ブタノール−イソプロパ
ノ−ルー水;7:7:6)であることを特徴とする新規
抗生物質5F−219’8物質およびその塩を提供する
ものである。
Therefore, the first aspect of the present invention is a white to pale yellow basic substance, and its hydrochloride is a white to pale yellow powder, easily soluble in water, methanol, ethyl acetate, chloroform,
It is sparingly soluble in alkaline water, and when its molecular weight is measured by secondary ion mass spectrometry, M/Z
, 95.2.854°822.511, the decomposition point is around 150°C, the specific optical rotation is [α 5-232° (c O15, water), and the first
The ultraviolet absorption spectrum as shown in the figure and the infrared absorption spectrum as shown in Fig. 2 indicate chromatography, and the color reaction is positive for Lemieux and iodine reagents, negative for ninhydrin and Itami reagents, and the silica gel thin layer The nf value in chromatography is Rf = 0,76C chloroform-methanol; 5:1)
T'Cf=0.67 (butanol-acetic acid-water; 2:1:
1) To provide a novel antibiotic 5F-219'8 substance and its salt, characterized in that 'Rf=0.71 (butanol-isopropanol-water; 7:7:6).

さらに第二の本発明によれば、アクチノマデユラ属に属
する抗生物質5F−2198物質生産菌を培養し、得ら
れた培養物から抗生物質5F−2198物質又はその塩
を採取することを特徴とする新規抗生物質5F−219
8物質又はその塩の製造法が提供される。
Furthermore, according to the second invention, there is provided a novel method characterized in that an antibiotic 5F-2198 substance-producing bacterium belonging to the genus Actinomadeura is cultured, and an antibiotic 5F-2198 substance or a salt thereof is collected from the obtained culture. Antibiotic 5F-219
A method for producing eight substances or salts thereof is provided.

新規抗生物質5F−2198物質生産山としては、その
培養物中に採取するに充分な情の5F−2198物質を
生産する能力を有するものであればいかなるものであっ
てもよいが、このような菌株の一例としては本発明者ら
により京都型の清水前の土壌より新たに分離された5F
−2’198株がある。5F−2198株の蘭学的性状
は下記の通シである。
The new antibiotic 5F-2198 substance production pile may be of any type as long as it has the ability to produce sufficient 5F-2198 substance to be collected in its culture. An example of a bacterial strain is 5F, which was newly isolated by the present inventors from Kyoto-type Shimizu-mae soil.
There are -2'198 strains. The orchidological properties of the 5F-2198 strain are as follows.

■、形態 基生菌糸はよく伸長分枝し、その直径は約0.5ミクロ
ンである。寒天培地及び液体培地のいずれにおいても基
生菌糸の分断は通常観察されない。
(2) The morphobase hyphae are well elongated and branched, and the diameter is about 0.5 micron. Subdivision of basal hyphae is usually not observed in either agar or liquid media.

気菌糸着生は非常に貧弱で、通常の放線菌の培養に用い
られるほとんどの培地上で着生しないが、リンゴ酸カル
シウム寒天では白色の気菌糸を着生し、胞子形成も良好
である。時にスターチ寒天で−もわずかに気菌糸が観察
される。気菌糸の分枝は単純分枝で車軸分枝はみられな
い。胞子のう、鞭毛胞子、菌核は観察されない。胞子の
連鎖は直鎖状、鉤状またはループ状となる。
Aerial mycelium is very poor and does not adhere to most of the media commonly used for culturing actinomycetes, but white aerial mycelium grows on calcium malate agar and spore formation is good. Sometimes, a few aerial mycelia are observed on starch agar. The branches of the aerial hyphae are simple branches, and no axle branches are observed. No sporangia, flagellated spores, or sclerotia are observed. Spore chains can be linear, hook-shaped, or loop-shaped.

電子顕微鐘で観察すると胞子は楕円型〜円筒型で0.6
〜0,7xO08〜1.3ミクロンの大きさを有し、胞
子の連鎖は5〜10ケの場合が多い。胞子の表面は大き
いしわ状乃至いぼ状である。
When observed with an electron microscope, the spores are oval to cylindrical and 0.6
It has a size of ~0.7xO08~1.3 microns, and chains of spores are often 5-10. The surface of the spores is large wrinkled or warty.

■、各種培地上の生育状態 S F −2198株の各種培地上の生育状態は次表に
示す通りである。色の記載、につぃて〔〕内に示す標準
は、コンテイナー・コー、ボレーション・オブ0アメリ
カ(Container Corporation o
fAmerica) 社Wの「カラー・ハーモニ−1マ
ニュアル(Co1or Harmony Manual
 ) Jに記載のものを用いた。観察は28℃で、14
〜21日培養後に行った。
(2) Growth status on various media The growth status of SF-2198 strain on various media is as shown in the following table. The color descriptions and standards shown in [ ] are those of the Container Corporation of America.
fAmerica) Company W's ``Color Harmony Manual''
) The one described in J was used. Observations were made at 28°C, 14
This was carried out after ~21 days of culture.

■、生理的性質 (1)生育温度範囲: スターチ寒天において15℃〜
40℃の温度範囲で生育し、26℃〜36℃が最適温度
である。
■Physiological properties (1) Growth temperature range: 15℃~ in starch agar
It grows in a temperature range of 40°C, with an optimum temperature of 26°C to 36°C.

(2)ゼラチンの液化: 陽性(20℃、20日培養) (3)スターチの加水分解: 陽性(28℃、14日培
養) (4)硝酸塩の還元: 陽性(28℃、14日培養)(
5)脱脂乳のペプトン化: 陰性(28℃、57℃、1
4日培養) 脱脂乳の凝固: 陰性(28°C237℃。
(2) Liquefaction of gelatin: Positive (cultured at 20°C, 20 days) (3) Hydrolysis of starch: Positive (cultured at 28°C, 14 days) (4) Reduction of nitrate: Positive (cultured at 28°C, 14 days) (
5) Peptonization of skim milk: Negative (28℃, 57℃, 1
4 days culture) Coagulation of skim milk: Negative (28°C, 237°C).

14日培養) (6)メラニン様色素の生成: 陰性 IV、炭素源の利用性(プリドハム・ゴツトリーブ寒天
培地): (1)利用する: D−グルコース、■、−アラビノー
ス、D−マンニトール、D−キシロース。
(14 day culture) (6) Production of melanin-like pigment: Negative IV, carbon source availability (Pridham-Gottlieb agar medium): (1) Use: D-glucose, ■, -arabinose, D-mannitol, D- xylose.

L−ラムノース、シュクロース (2)利用が疑わしい: D−フラクトース(3)利用
しない: I−イノシトール、ラフィノース ■、細胞壁組成: 5F−2198株の全細胞加水分解物中にメソ−ジアミ
ノピメリン酸及びマデュロースカ認められた。
L-rhamnose, sucrose (2) usage is questionable: D-fructose (3) not used: I-inositol, raffinose■, cell wall composition: meso-diaminopimelic acid and maduroseka in whole cell hydrolyzate of 5F-2198 strain Admitted.

以上の性状より、5F−2198株は放線菌の中でアク
チノマデユラ(Act ino+nadura )属に
属する菌株である。従って1本発明者らは5F−219
8株をアクチノマデユラ・エスピー・SF−2198(
Actinomadura sp、5F−2198)と
命名した。
Based on the above properties, strain 5F-2198 is a strain belonging to the genus Actino+nadura among actinomycetes. Therefore, 1 the inventors
8 strains of Actinomadeura sp. SF-2198 (
Actinomadura sp, 5F-2198).

本菌株は微工研に寄託されており、その做工研受託番号
は第6650号である。
This strain has been deposited with the Microtech Institute, and its accession number is No. 6650.

8F−2198株は他の放線菌の多くの菌株の場合にみ
られるようにその性質が変化しやすく、例えば紫外線、
エックス線、放射線、薬品等を用いる人工的変異手段で
変異しうるものであるが、いずれの変異株であっても5
F−2198物質の生産能を有するアクチノマデユラ属
の菌株はすべて本発明の方法に使用することができる。
The properties of the 8F-2198 strain are susceptible to change, as is the case with many other strains of actinomycetes, such as exposure to ultraviolet light,
Although it can be mutated by artificial mutation methods using X-rays, radiation, chemicals, etc., any mutant strain
All strains of the genus Actinomadeura that have the ability to produce the F-2198 substance can be used in the method of the present invention.

本発明の方法では、前記菌株を通常の微生物が利用しう
る栄養物を含有する培地で培養する。栄養源としては従
来、放線菌の培養に利用されている公知のものが使用で
きる。例えば、炭素源としてグルコース、グリセロール
、澱粉、シュクロース、デキストリン、水あめ、糖みつ
、植物油、動物油等が使用できる。又、窒素源としては
大豆粉。
In the method of the present invention, the strain is cultured in a medium containing nutrients that can be utilized by common microorganisms. As the nutrient source, any known nutrient source conventionally used for culturing actinomycetes can be used. For example, glucose, glycerol, starch, sucrose, dextrin, starch syrup, molasses, vegetable oil, animal oil, etc. can be used as the carbon source. Also, soybean flour is used as a nitrogen source.

小麦胚芽、肉エキス、ペプトン、酵母エキス、乾燥酵母
、コーンステイープリカー、綿実かす、魚粉、硫酸アン
モニウム、硝酸ソーダ、尿素等を使用しうる。その他必
要に応じて炭酸カルシウム。
Wheat germ, meat extract, peptone, yeast extract, dried yeast, cornstap liquor, cottonseed meal, fish meal, ammonium sulfate, sodium nitrate, urea, etc. may be used. Calcium carbonate as needed.

塩化す) IJウム、塩化コバルト、燐酸塩等の無機塩
類を添加する。−!た、菌の発育を助け、5F−219
8物質の生産を促進することができる有機及び無機物を
適当に添加することができる。
Add inorganic salts such as cobalt chloride, cobalt chloride, and phosphate. -! 5F-219 helps the growth of bacteria.
Organic and inorganic substances that can promote the production of 8 substances can be appropriately added.

培養法としては液体深部培養も可能であるが、寒天培養
が比較的生産性が良く適している。培養に適当な温度は
26〜56℃である。5F−2198物質の生産は5〜
15日で蓄積が最高に達する。
As a culture method, deep liquid culture is also possible, but agar culture is suitable because it has relatively good productivity. A suitable temperature for culturing is 26-56°C. The production of 5F-2198 substance is 5~
Accumulation reaches its maximum in 15 days.

5F−2198物質の検定に当っては、バチルス・ズブ
チリス(Bacillus 5ubtilis ) A
 T CC6633を被検菌とする生物検定法を用いる
。この検定法では、S、F−2198物質が0.625
mcg /TLl〜10 mcg /mlの濃度範囲で
その対数と阻止円径との間に直線関係が成立し、それぞ
れ11〜21龍の阻止円径を与える。
For assaying the 5F-2198 substance, Bacillus subtilis A
A bioassay method using TCC6633 as the test bacterium is used. In this assay method, S, F-2198 substance is 0.625
In the concentration range from mcg/TLl to 10 mcg/ml, a linear relationship is established between its logarithm and the inhibition circle diameter, giving inhibition circle diameters of 11 to 21 L, respectively.

5F−2198物質は後記する理化学的性状を有するの
で、その性状に従って抽出、精製することが可能である
が、以下の方法により効率的に抽出、精製できる。すな
わち、有効成分は、寒天を凍結融解する際の水層部分お
よびその残りの固型物から50係アセトン水での抽出液
の両者に含まれている。50俤アセトン抽出液はアセト
ンを留去後、前者の水層部分と合併し、これをダイヤイ
オンHP−20(三菱化成)等の多孔性吸着樹脂に吸着
させ、アセトン、メタノール等の水と自由に混合できる
有機溶媒と水との混合溶媒で有効成分を溶出する。さら
に有機溶媒を留去したのち、pi(9に調整し、ブタノ
ール、酢酸エチル等の溶媒で抽出し、さらにpH2の水
へ転溶させ凍結乾燥し8F−2198物質の粗粉末を得
る。この粗粉末を、CMセファデックス(ファルマシア
社り。
Since the 5F-2198 substance has the physical and chemical properties described below, it can be extracted and purified according to its properties, and can be efficiently extracted and purified by the following method. That is, the active ingredient is contained both in the aqueous layer obtained when agar is frozen and thawed and in the extract from the remaining solid matter with 50% acetone water. After distilling off the acetone, the acetone extract is combined with the aqueous layer of the former, and this is adsorbed onto a porous adsorption resin such as Diaion HP-20 (Mitsubishi Kasei), and then mixed with water such as acetone, methanol, etc. The active ingredient is eluted with a mixed solvent of water and an organic solvent that can be mixed with water. After further distilling off the organic solvent, the pi (adjusted to 9) was extracted with a solvent such as butanol or ethyl acetate, and further dissolved in water at pH 2 and lyophilized to obtain a crude powder of 8F-2198 substance. Powder, CM Sephadex (manufactured by Pharmacia).

セファデックスG−10(ファルマシア社製)等のカラ
ムクロマトグラフィーを適宜組合わせ使用することによ
り精製し、5F−2198物質の純品を得る。かくして
得られた5F−2198物質は各種の溶媒系での薄層ク
ロマトグラフィーでいずれも単一の、スポットを与える
ことから純品であると判断される。なお1本物質は遊離
塩基では不安定なので塩酸塩として純品を得ている。
Purification is performed by using a suitable combination of column chromatography such as Sephadex G-10 (manufactured by Pharmacia) to obtain a pure 5F-2198 substance. The 5F-2198 substance thus obtained was judged to be a pure product since it gave a single spot in thin layer chromatography using various solvent systems. Note that this substance is unstable in its free form, so it was obtained as a pure product as a hydrochloride.

本発明の8F−2198物質の塩酸塩の理化学的性状は
以下のとおりである。
The physicochemical properties of the hydrochloride of the 8F-2198 substance of the present invention are as follows.

元素分析:炭素47.64係、水素5.88係、窒素4
.24係、硫黄10.27係、ハロゲン8.42係。
Elemental analysis: carbon 47.64 parts, hydrogen 5.88 parts, nitrogen 4 parts
.. 24 units, sulfur 10.27 units, halogen 8.42 units.

分子緻:セカンダリイ・イオン質量スペクトル法(SI
MS)でM/Z 932.854.822.511にイ
オンピークが観測された。(本物質の遊離塩基をフィー
ルド・デソープション質赦スはクトル法(FDMS )
で測定した結果、M/Z510にピークが観測された。
Molecular precision: Secondary ion mass spectrometry (SI
MS), an ion peak was observed at M/Z 932.854.822.511. (Field desorption of the free base of this substance is carried out using the Kutle method (FDMS).
As a result of measurement, a peak was observed at M/Z510.

) 融点(分解点):150’C:付近から着色しはじめ、
16UJ℃付近で褐変し、それ以後26 [1’Cまで
温度を上昇させても変化は認められなかった。
) Melting point (decomposition point): 150'C: Starts to color from around 150'C,
Browning occurred at around 16 UJ°C, and no change was observed even after the temperature was raised to 26[1'C].

比旋光度:〔α〕ル5−232°(cO05,水)紫外
線吸収スペクトル:第1図に示すごとく明確な吸収極大
を示さず下記の波長付近に肩を示す。
Specific optical rotation: [α] 5-232° (cO05, water) Ultraviolet absorption spectrum: As shown in FIG. 1, there is no clear absorption maximum, but a shoulder near the following wavelengths.

(1)水浴液中:270nm(肩)(B:二76)。(1) In water bath solution: 270 nm (shoulder) (B: 276).

520 nm (肩)(E’、’432>。520 nm (shoulder) (E', '432>.

(2)、 0.1規定硫酸仲: 270 nm (肩) (Bicm (Ss )。(2), 0.1N sulfuric acid medium: 270 nm (shoulder) (Bicm (Ss).

520 nm (屑)(H,、#l2B)。520 nm (scrap) (H, #l2B).

(3)0.1規定苛性ソーダ中: 250 nm (肩)(El、120)。(3) In 0.1N caustic soda: 250 nm (shoulder) (El, 120).

280 nm (肩)(B1.、 80)。280 nm (shoulder) (B1., 80).

550 nm (肩)(El。 52)。550 nm (shoulder) (El. 52).

赤外線吸収スにクトル:第2図に示す。Infrared absorption vector: Shown in Figure 2.

呈色反応ニレミュー、ヨード試薬に対し陽性。Color reaction Niremu, positive for iodine reagent.

ニンヒドリン、板目試薬に対し陰性。Negative for ninhydrin and plate reagent.

外観:白ないし淡黄色粉末。Appearance: White to pale yellow powder.

中性、酸性、塩基性の区別:高圧p紙電気泳動(+)H
IS、4.3000V、15分泳動)の結果、陰極側ヘ
アラニンの2.2倍泳動することおよび精製挙動より塩
基性物質と考えられる。
Distinction between neutral, acidic, and basic: High pressure p paper electrophoresis (+) H
IS, 4.3000V, 15 minutes), it migrated 2.2 times as much as hairlanin on the cathode side, and it is considered to be a basic substance based on its purification behavior.

シリカゲル薄層クロマトグラフィー: Rf=0.76(クロロホルム−メタノール;5:1)
=0.67(ブタノール−酢酸−水;2:1:1)=0
.71(ブタノール−イソプロパノ−ルー水;7:7:
6)溶解性:水、メタノールに易溶。
Silica gel thin layer chromatography: Rf=0.76 (chloroform-methanol; 5:1)
= 0.67 (butanol-acetic acid-water; 2:1:1) = 0
.. 71 (butanol-isopropanol-water; 7:7:
6) Solubility: Easily soluble in water and methanol.

酢酸エチル、クロロホルム、塩基性水に難溶。Slightly soluble in ethyl acetate, chloroform, and basic water.

8F−2198物質の各種検定菌に対する最小阻止濃度
は第1表に示すとおりで、グラム陽性菌及び陰性菌に対
し非常に強い抗1作を示している。
The minimum inhibitory concentration of substance 8F-2198 against various test bacteria is shown in Table 1, and it shows very strong anti-activity against Gram-positive bacteria and Gram-negative bacteria.

また、マウスを用いた急性毒性を5 Q my 、/ 
kgで1群2匹、腹腔内投与で試験したが、金側死亡し
た。
In addition, the acute toxicity using mice was 5 Q my, /
A test was conducted using intraperitoneal administration of 2 animals per group at 1 kg, but some died on the gold side.

従って本物質は医薬品、動物薬、殺菌消毒剤あるいはそ
れらの合成中間体として有用である。
Therefore, this substance is useful as a pharmaceutical, veterinary drug, bactericidal disinfectant, or a synthetic intermediate thereof.

前記した理化学的性状および生物学的性状を有する8F
−2198物質は、いずれの既知物質とも異なり、新規
物質であると判定した。
8F having the above-mentioned physical and chemical properties and biological properties
Substance -2198 was determined to be a new substance, unlike any known substance.

第  1  表 以下に5F−2198物質の製造法の実施例を示すが、
ここに例示されない多くの変形、修飾手段を用いうるこ
とは言うまでもない。
Below in Table 1, examples of the method for producing 5F-2198 substance are shown.
It goes without saying that many modifications and modification means not exemplified here can be used.

実施例1 (1)SF−2198株の培養 種菌としてスターチ斜面寒天培地に28℃、14日間培
養したアクチノマデユラ・エスピー・8F−2198株
(微工研菌寄第665o号)を用いた。種培地としては
可溶性澱粉1.(In、  グルコース1.0%、ポリ
ペプトン0.5係、酵母エキス0.5係、肉エキス0.
2’l、大豆かす0.2%、炭酸カルシウム0.1係及
び水道水からなる液体培地(pI(無d周整)を用いた
Example 1 (1) Culture of SF-2198 strain Actinomadeura sp. 8F-2198 strain (Feikoken Bibori No. 665o), which had been cultured on a starch slanted agar medium at 28° C. for 14 days, was used as the inoculum. As a seed medium, soluble starch 1. (In, glucose 1.0%, polypeptone 0.5 parts, yeast extract 0.5 parts, meat extract 0.
A liquid medium (pI (no d-period adjustment)) consisting of 2'l of soybean meal, 0.2% of soybean meal, 0.1% of calcium carbonate, and tap water was used.

予め、100m1容三角フラスコに滅菌ずみの上記種培
地2r3mlに種菌を5〜6白金白金押接、これを28
℃で3日間ロータリーシェーカーを用いて撮盪培養し、
そのl@養物を種培養とした(三角フラスコ7本使用)
In advance, in a 100 ml Erlenmeyer flask, 5 to 6 platinum seeds were pressed into 2 r3 ml of the above sterilized seed medium, and 28
Culture with shaking using a rotary shaker for 3 days at °C.
The l@nutrient was used as seed culture (using 7 Erlenmeyer flasks)
.

グルコース1.25係、小麦肚V−1,0係、サングレ
イン(ザントリー製)0.25係9食塩0.125係、
粉末寒天2.0%及び水道水よりなる生産培地(滅菌前
〆I7゜0)61を滅菌後、60枚の大型ベトリ皿(直
径23CIIL、高さ6.5cm)に200m1づつ分
注する。寒天が固まった後に、前記の種培養を各ば) 
IJ皿にd mlづつ分注接種し、滅菌したガラス棒を
用いて寒天表面全体に種を塗りつけ、その後28℃の培
養室中で10日間静、装培養する。
Glucose 1.25 part, Wheat Belly V-1.0 part, Sungrain (manufactured by Zantry) 0.25 part 9 Salt 0.125 part,
After sterilization, a production medium consisting of 2.0% powdered agar and tap water (I7°0 before sterilization) 61 is dispensed into 60 large veterinary dishes (diameter 23 CIIL, height 6.5 cm) in 200 ml portions. After the agar has solidified, add the seed culture as described above)
The seeds are inoculated in dml portions into IJ dishes, and the seeds are smeared onto the entire surface of the agar using a sterilized glass rod, followed by static culture for 10 days in a culture room at 28°C.

培養後、ベトリ皿中の寒天培養物を取り出してステンレ
スのトレイに移し、−20℃のフリーザーに入れて凍結
する。凍結した寒天培養物をついで熱水を用いて融解し
くトレイの外側を熱水で加温)、これに濾過助剤として
ケイソウ土を加えて直ちに濾過し、寒天と菌体を含む固
型物とろ液(5,41)とに分離する。5F−2198
物質は主に培養Ffffl中に含まれるが、固型物中に
も残存する。固型物中の8F−2198物質は50チア
セトA s i )を用いて抽出した。
After culturing, the agar culture in the vetri dish is taken out, transferred to a stainless steel tray, and frozen in a -20°C freezer. The frozen agar culture is then thawed using hot water (heating the outside of the tray with hot water), diatomaceous earth is added as a filter aid and immediately filtered to remove the solids containing agar and bacterial cells. It separates into liquid (5, 41). 5F-2198
The substance is mainly contained in the cultured Ffffl, but also remains in the solid material. The 8F-2198 substance in the solid was extracted using 50 thiacetate As i ).

(21S F −2198!吻質)抽出・精製50チア
セトン水での抽出液(5,4g)のアセトンを減圧下で
留去した後、ろ液(51)と合併し、ダイヤイオンHP
−20(三菱化成製)40oilの塔にかけ、有効成分
を吸着させた。この塔を水、50係メタノール水で順次
洗い、80係アセトン水で有効成分を溶出させた。活性
区分11を合併し、アセトンを減圧下で留去後、pH9
で有効成分を酢酸エチル200m1に抽出し、さらにp
H2の水2001m1で有効成分を水層に転溶させた。
(21S F-2198! Snostum) Extraction and Purification 50 After distilling off the acetone of the extract (5.4 g) with thiacetone water under reduced pressure, it was combined with the filtrate (51), and the Diaion HP
-20 (manufactured by Mitsubishi Kasei) was applied to a column of 40 oil to adsorb the active ingredients. The column was sequentially washed with water and 50% methanol water, and the active ingredient was eluted with 80% acetone water. After combining the active sections 11 and distilling off the acetone under reduced pressure, the pH was adjusted to 9.
Extract the active ingredients into 200 ml of ethyl acetate, and
The active ingredient was transferred to the aqueous layer with 2001 ml of H2 water.

水層をpH4に調整し、減圧下で501111まで濃縮
し、CMセファデックス(ファルマシア社製Σ200m
1の塔にかけ、有効成分を吸着させた。この塔を水洗後
、0.1モル食塩水で有効成分を溶出させ、活性区分1
20m1を合併し、ダイヤイオン)−I I) −20
の15m/!の塔にかけて有効成分を吸着させた。
The aqueous layer was adjusted to pH 4, concentrated to 501111 under reduced pressure, and
1 column to adsorb the active ingredients. After washing this tower with water, the active ingredient was eluted with 0.1 molar saline solution, and active ingredient 1
20m1 merged, Diamond ion)-I I)-20
15m/! The active ingredients were adsorbed in the column.

水、50係メタノール水でこの塔を順次洗い、80チア
セトン水で有効成分を溶出させ、活性区分40m1を合
併し、pHを4.8に調整後、減圧下でC層線し、さら
に凍結乾燥して純度80係の粉末13myを得た。
The column was sequentially washed with water and 50% methanol water, the active ingredient was eluted with 80% thiacetone water, 40ml of active fraction was combined, the pH was adjusted to 4.8, the C layer was formed under reduced pressure, and then freeze-dried. Thus, 13 my of powder with a purity of 80 was obtained.

実施例2 実施例1の方法をくりかえし実施することにより鍔られ
た純度80fl)の粉末35 mr)を30憾メタノ一
ル水5mlに溶解し、セファデックスId−T−20(
ファルマシア社製)の250m1の塔にかケ、り0係メ
タノール(′550m1)、604メタノール(60(
3rnl)、9CJ’lyメタ/−ル(2,17’)f
順次展開し、活性区分(25oil)を合併し、減圧濃
縮後凍結乾燥して45m9の5F−2198物質の純品
粉末を得た。
Example 2 35 ml of powder with a purity of 80 fl) obtained by repeating the method of Example 1 was dissolved in 5 ml of 30 methanol water, and Sephadex Id-T-20 (
In a 250 m1 tower of Pharmacia (manufactured by Pharmacia), 0 methanol ('550 m1), 604 methanol (60 (
3rnl), 9CJ'ly meta/-ru (2,17')f
The active fractions (25 oil) were sequentially expanded, concentrated under reduced pressure, and then lyophilized to obtain 45 m9 of pure powder of 5F-2198 substance.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は5F−2198物質の紫外線吸収スペクトルで
あり、(1)は中性の水、(2)は0.1規定硫酸、(
′5)は0.1規定苛性ソーダで、いずれも25mcg
/mlの濃度で測定したものである。第2図は5F−2
198物質の赤外線吸収スはクトルであり、臭化カリウ
ム錠として測定したものである1、手続補正書(自発) 昭和57年11月15日 特許庁長官殿 1、事件の表示 昭和 57年特許願第162291号 2、発明の名称 新規抗生物質8F−2198物質およびその製造法 3、補正をする者 事イど1との関係     特許出願人住 所 東京都
中央区京橋二丁目4番16号(609)名称  明治製
菓株式会社 4、代理人 〒105  住所 東京都港区西新橋1丁目1番15号
物産ビル別館 電話(591) 0261よ補正の対象 明細書の特許請求の範囲の11・u及び発明の詳A11
1な説明の欄 6、補正の内容 (1)%許請求の範囲を別紙のとおシ補正する。 (−2)明卸1剖第3頁12行の「であり」を削除して
「から着色しはじめ、ito℃イ;J近で褐変し」を挿
入する。 (3)同第14’頁下から弘行のrN/HJJをrNI
HJ Jと補正する。 特許請求の範囲 t 白色ないし淡黄色の塩基性物質であり、その塩酸塩
は白色ないし淡黄色粉末であり、水、メタノールに易溶
、酢酸エチル、クロロホルム、アルカリ性水に難溶であ
り、その分子量についてセカンダリイ・イオン質量スペ
クトル法で測定すると、M/Z  932.、♂j弘、
122.j//にイオン・ピークを示し、その分解点は
tro℃付近から着色しはじめ、ito℃付近で褐変し
、比旋光度は〔α〕25−コ3コ’ (c O,夕、水
)であり、第7図に示り す通りの紫外線吸収スペクトルと第2図に示す通シの赤
外線吸収スペクトルを示し、呈色反応はレミュー、ヨー
P試薬に対し陽性で、ニンヒドリン。 板目試薬に対し陰性であり、シリカゲル薄層クロマトグ
ラフィーでのRf値は、 Rf = 0.7ぶ(クロロホルム−メタノール;J−
:/)R,f=θ、t7(ブタノール−酢酸−水;λ:
/:/)几f=0.71(ブタノールーイソゾロノぞノ
ール−水ニア:7:A)であることを特徴とする新規抗
生物質5F−2/f#物質およびその塩。 2 アクチノマデユラ属に属する抗生物質8F−2/り
を物質生産菌を培養し、得られた培養物から抗生物質8
F−2191物質又はその塩を採取することを特徴とす
る新規(〕1.生物5isF−,ztqg物質又はその
塩の製造法。
Figure 1 shows the ultraviolet absorption spectrum of 5F-2198 substance, (1) is neutral water, (2) is 0.1N sulfuric acid, (
'5) is 0.1N caustic soda, both 25mcg
It was measured at a concentration of /ml. Figure 2 is 5F-2
The infrared absorption of 198 substances was measured as a potassium bromide tablet. 1. Procedural amendment (voluntary) November 15, 1980 To the Commissioner of the Japan Patent Office 1. Indication of the case 1988 Patent application No. 162291 2, Name of the invention Novel antibiotic 8F-2198 substance and its manufacturing method 3, Relationship with the person making the amendment No. 1 Patent applicant address 2-4-16 Kyobashi, Chuo-ku, Tokyo (609 ) Name Meiji Seika Co., Ltd. 4, Agent 105 Address Bussan Building Annex, 1-15 Nishi-Shinbashi, Minato-ku, Tokyo Phone: (591) 0261 Claims 11.u and invention of the specification subject to amendment Details A11
1 Explanation Column 6, Contents of Amendment (1) % The scope of the claims will be amended on a separate sheet. (-2) Delete "de" on page 3, line 12 of Meisho 1, and insert "begins to become colored and turns brown near ITO C; J." (3) From the bottom of page 14', Hiroyuki's rN/HJJ is rNI
Correct as HJ J. Claims t It is a white to pale yellow basic substance, and its hydrochloride is a white to pale yellow powder, easily soluble in water and methanol, slightly soluble in ethyl acetate, chloroform, and alkaline water, and its molecular weight When measured by secondary ion mass spectrometry, M/Z is 932. , ♂j Hiroshi,
122. It shows an ion peak at j//, and its decomposition point begins to change color around tro℃, turns brown around ito℃, and has a specific optical rotation of [α]25-co3co' (c O, evening, water). It showed an ultraviolet absorption spectrum as shown in Figure 7 and a general infrared absorption spectrum as shown in Figure 2, and the color reaction was positive for Lemieux and Yoo P reagents and ninhydrin. It was negative for the plate reagent, and the Rf value by silica gel thin layer chromatography was Rf = 0.7bu (chloroform-methanol; J-
:/) R, f=θ, t7 (butanol-acetic acid-water; λ:
/:/) A novel antibiotic 5F-2/f# substance and its salt, characterized in that f=0.71 (butanol-isozorononol-water: 7:A). 2. Cultivate bacteria producing the substance 8F-2 belonging to the genus Actinomadeura, and extract antibiotic 8F-2 from the resulting culture.
Novel (1. Method for producing biological 5isF-, ztqg substance or salt thereof) characterized by collecting F-2191 substance or salt thereof.

Claims (1)

【特許請求の範囲】 1、 白色ないし淡黄色の塩基性物質であり、その塩酸
塩は白色ないし淡黄色粉末であり、水、メタノールに易
溶、酢酸エチル、クロロホルム、アルカリ性水に難溶で
あり、その分子量についてセカンダリイ・イオン質量ス
ペクトル法で測定すると、M/Z  952,854,
822,511にイオン・ピークを示し、その分解点は
150℃付近であり、比旋光度は〔α几5−232°(
c O,5、水〕であり、第1図に示す通りの紫外線吸
収スペクトルと第2図に示す通りの赤外線吸収スにクト
ルを示し、呈色反応はレミュー、ヨード試4薬に対し陽
性で、ニンヒドリン、板目試薬に対し陰性であり、シリ
カゲル薄層クロマトグラフィーでのnf値は、Rf=0
.76(クロロホルム−メタノール;s:i’)Rf=
0.67(ブタノール−酢酸−水; 2:1:1)Rf
= 0.71 (ブタノール−イソプロパノ−ルー水;
7:7:6)であることを特徴とする新規抗生物質5F
−2198物質およびその塩。 2、 アクチノマデユラ属に属する抗生物質8F−21
98物質生産菌を培養し、得られた培養物から抗生物質
5F−2198物質又はその塩を採取することを特徴と
する新規抗生物質8F−2198物質又はその塩の製造
法。
[Scope of Claims] 1. It is a white to pale yellow basic substance, and its hydrochloride is a white to pale yellow powder, easily soluble in water and methanol, and slightly soluble in ethyl acetate, chloroform, and alkaline water. , when its molecular weight was determined by secondary ion mass spectrometry, M/Z was 952,854,
It shows an ion peak at 822,511, its decomposition point is around 150℃, and the specific optical rotation is [α几5-232°(
c O, 5, water], and showed a spectrum in the ultraviolet absorption spectrum as shown in Figure 1 and in the infrared absorption spectrum as shown in Figure 2, and the color reaction was positive for the Lemieux and iodine reagents. , ninhydrin, and the cross-grain reagent, and the nf value in silica gel thin layer chromatography is Rf = 0.
.. 76 (chloroform-methanol; s:i') Rf=
0.67 (butanol-acetic acid-water; 2:1:1) Rf
= 0.71 (butanol-isopropanol-water;
7:7:6) Novel antibiotic 5F
-2198 substance and its salt. 2. Antibiotic 8F-21 belonging to the genus Actinomadeura
1. A method for producing a novel antibiotic 8F-2198 substance or a salt thereof, which comprises culturing a 98 substance-producing bacterium and collecting the antibiotic 5F-2198 substance or a salt thereof from the resulting culture.
JP57162291A 1982-09-20 1982-09-20 Novel antibiotic sf-2198 substance and its preparation Pending JPS5951795A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57162291A JPS5951795A (en) 1982-09-20 1982-09-20 Novel antibiotic sf-2198 substance and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57162291A JPS5951795A (en) 1982-09-20 1982-09-20 Novel antibiotic sf-2198 substance and its preparation

Publications (1)

Publication Number Publication Date
JPS5951795A true JPS5951795A (en) 1984-03-26

Family

ID=15751689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57162291A Pending JPS5951795A (en) 1982-09-20 1982-09-20 Novel antibiotic sf-2198 substance and its preparation

Country Status (1)

Country Link
JP (1) JPS5951795A (en)

Similar Documents

Publication Publication Date Title
JPH01193265A (en) Novel antitumor antibiotic sf2587 substance and its production
JPH0329079B2 (en)
US4346075A (en) Antibiotic DC-11 and process for production thereof
JPS5951795A (en) Novel antibiotic sf-2198 substance and its preparation
US4162305A (en) Antibiotic XK-99 and process for production thereof
JP2592468B2 (en) Benanomycins A and B, novel antibiotics and their production
JPS6250473B2 (en)
KR830000618B1 (en) Preparation method of new antibiotic SF-2050B
JPH05310766A (en) New antibiotic substance mi481-42f4-a and its produciton
JPH0398591A (en) New antibiotic substance having antitumor activity and production thereof
JP3327982B2 (en) New antibiotic MI481-42F4-A related substance
JP2594085B2 (en) SF2575, a new antitumor antibiotic, and method for producing the same
JPS62186787A (en) Novel microorganism
JPS63192792A (en) Novel antibiotic sf 2487 substance and production thereof
JPS6210229B2 (en)
JPS63146784A (en) Novel strain streptomyces rubropurpureus
JPH0272183A (en) Antibiotic wk-2057 and production thereof
JPS60224493A (en) Novel antibiotic sf-2312 substance and its preparation
JPS58319B2 (en) New antibiotic SF-1917 substance and its manufacturing method
JPH0662632B2 (en) Novel antibiotic A1-R2397 substance and its production method
JPH08208644A (en) New antibiotic substance cremimycin, its production and use
JPS6188885A (en) Novel antibiotic substance sf-2370 and its preparation
JPH021838B2 (en)
JPH0374678B2 (en)
JPS61219390A (en) New cytocidal antibiotic 82-85-8a and production thereof